Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanoparticles for the treatment of liver fibrosis
Suchithra Poilil Surendran, Reju George Thomas, Myeong-Ju Moon, et al.
International Journal of Nanomedicine (2017) Vol. Volume 12, pp. 6997-7006
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Erika Hernández‐Aquino, Pablo Muriel
World Journal of Gastroenterology (2018) Vol. 24, Iss. 16, pp. 1679-1707
Open Access | Times Cited: 293
Liver Fibrosis Resolution: From Molecular Mechanisms to Therapeutic Opportunities
Qiying Pei, Qian Yi, Liling Tang
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9671-9671
Open Access | Times Cited: 50
Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy
Shrawani Lamichhane, Sang Kil Lee
Archives of Pharmacal Research (2020) Vol. 43, Iss. 1, pp. 118-133
Closed Access | Times Cited: 104
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Arshi Khanam, Paul Saleeb, Shyam Kottilil
Cells (2021) Vol. 10, Iss. 5, pp. 1097-1097
Open Access | Times Cited: 84
Nanoparticles in the diagnosis and treatment of vascular aging and related diseases
Hui Xu, Shuang Li, You‐Shuo Liu
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 57
Harnessing reactive oxygen/nitrogen species and inflammation: Nanodrugs for liver injury
Min Liu, Qiong Huang, Yan Zhu, et al.
Materials Today Bio (2022) Vol. 13, pp. 100215-100215
Open Access | Times Cited: 56
Multiscale biomechanics and mechanotransduction from liver fibrosis to cancer
Ning Li, Xiaoyu Zhang, Jin Zhou, et al.
Advanced Drug Delivery Reviews (2022) Vol. 188, pp. 114448-114448
Open Access | Times Cited: 51
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities
Eleonora Binatti, Alessio Gerussi, Donatella Barisani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6649-6649
Open Access | Times Cited: 40
Lysosomal nanotoxicity: Impact of nanomedicines on lysosomal function
Mariia Uzhytchak, Barbora Smolková, Mariia Lunová, et al.
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114828-114828
Closed Access | Times Cited: 29
Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents
Lin Chen, Wenyan Guo, Chun Mao, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 6, pp. 1446-1466
Closed Access | Times Cited: 13
Selective phytochemicals targeting pancreatic stellate cells as new anti-fibrotic agents for chronic pancreatitis and pancreatic cancer
P. Ramakrishnan, Wei Mee Loh, Subash C. B. Gopinath, et al.
Acta Pharmaceutica Sinica B (2019) Vol. 10, Iss. 3, pp. 399-413
Open Access | Times Cited: 71
Hydrogen Sulfide as a Novel Regulatory Factor in Liver Health and Disease
Dongdong Wu, Dayong Wang, Huimin Li, et al.
Oxidative Medicine and Cellular Longevity (2019) Vol. 2019, pp. 1-16
Open Access | Times Cited: 70
Liver-targeted delivery of TSG-6 by calcium phosphate nanoparticles for the management of liver fibrosis
Min Wang, Miao Zhang, Lian‐Hua Fu, et al.
Theranostics (2019) Vol. 10, Iss. 1, pp. 36-49
Open Access | Times Cited: 58
It’s all about the spaces between cells: role of extracellular matrix in liver fibrosis
Amit Khurana, Nilofer Sayed, Prince Allawadhi, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 8, pp. 728-728
Open Access | Times Cited: 55
Synthesis of Fe3O4/Ag nanohybrid ferrofluids and their applications as antimicrobial and antifibrotic agents
Ahmad Taufiq, Rosy Eko Saputro, Hendra Susanto, et al.
Heliyon (2020) Vol. 6, Iss. 12, pp. e05813-e05813
Open Access | Times Cited: 54
The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi, et al.
Bioinorganic Chemistry and Applications (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 41
Mesenchymal stromal cells: promising treatment for liver cirrhosis
Lichao Yao, Xue Hu, Kai Dai, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Targeting Hepatic Stellate Cell Death to Reverse Hepatic Fibrosis
Xiangting Zhang, Yuan Zeng, Luying Zhao, et al.
Current Drug Targets (2023) Vol. 24, Iss. 7, pp. 568-583
Closed Access | Times Cited: 19
Nanoparticle drug delivery systems in hepatocellular carcinoma: A focus on targeting strategies and therapeutic applications
Sayali Pravin Metkar, Gasper Fernandes, Prerana D. Navti, et al.
OpenNano (2023) Vol. 12, pp. 100159-100159
Open Access | Times Cited: 19
Resveratrol contributes to the inhibition of liver fibrosis by inducing autophagy via the microRNA‑20a‑mediated activation of the PTEN/PI3K/AKT signaling pathway
Li Zhu, Qiuju Mou, Yinghui Wang, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 2035-2046
Open Access | Times Cited: 43
Biosynthesis of silver nanoparticles using isolated Bacillus subtilis: characterization, antimicrobial activity, cytotoxicity, and their performance as antimicrobial agent for textile materials
Magda A. El‐Bendary, Salwa Afifi, Maysa E. Moharam, et al.
Preparative Biochemistry & Biotechnology (2020) Vol. 51, Iss. 1, pp. 54-68
Closed Access | Times Cited: 40
Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia
Jordi Ribera, Clara Vilches, Vanesa Sanz, et al.
ACS Nano (2021) Vol. 15, Iss. 4, pp. 7547-7562
Closed Access | Times Cited: 34
Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy
Liyue Zhou, Qiangwei Liang, Yifan Li, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 235-254
Closed Access | Times Cited: 25
Synthesis and Characterization of Fatty Acid Grafted Chitosan Polymeric Micelles for Improved Gene Delivery of VGF to the Brain through Intranasal Route
Richard Nii Lante Lamptey, Avinash Gothwal, Riddhi Trivedi, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 493-493
Open Access | Times Cited: 24
When healing turns into killing – the pathophysiology of pancreatic and hepatic fibrosis
Paweł E. Ferdek, Daria Krzysztofik, Kinga B. Stopa, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 11, pp. 2579-2612
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top